PortfoliosLab logoPortfoliosLab logo
SBS vs. ETON
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SBS vs. ETON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) and Eton Pharmaceuticals Inc (ETON). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBS achieves a 15.28% return, which is significantly lower than ETON's 86.81% return.


SBS

1D
-0.18%
1M
-6.98%
YTD
15.28%
6M
14.60%
1Y
38.40%
3Y*
40.12%
5Y*
32.68%
10Y*
16.43%

ETON

1D
-1.62%
1M
2.50%
YTD
86.81%
6M
89.16%
1Y
117.71%
3Y*
102.22%
5Y*
36.00%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBS vs. ETON - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
SBS
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
15.28%80.60%-4.21%46.89%48.42%-13.79%-40.98%91.22%10.55%
ETON
Eton Pharmaceuticals Inc
86.81%26.95%204.11%55.32%-34.27%-47.23%12.92%17.65%-4.23%

Correlation

The correlation between SBS and ETON is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Nov 13, 2018

0.16

Fundamentals

Market Cap

SBS:

$19.24B

ETON:

$996.57M

EPS

SBS:

R$2.48

ETON:

-$0.05

PS Ratio

SBS:

2.48

ETON:

10.20

PB Ratio

SBS:

2.27

ETON:

32.55

Total Revenue (TTM)

SBS:

R$38.70B

ETON:

$86.93M

Gross Profit (TTM)

SBS:

R$13.96B

ETON:

$47.61M

EBITDA (TTM)

SBS:

R$14.87B

ETON:

$5.70M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBS vs. ETON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBS
SBS Risk / Return Rank: 7373
Overall Rank
SBS Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
SBS Sortino Ratio Rank: 7373
Sortino Ratio Rank
SBS Omega Ratio Rank: 6969
Omega Ratio Rank
SBS Calmar Ratio Rank: 7171
Calmar Ratio Rank
SBS Martin Ratio Rank: 7676
Martin Ratio Rank

ETON
ETON Risk / Return Rank: 8787
Overall Rank
ETON Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
ETON Sortino Ratio Rank: 8888
Sortino Ratio Rank
ETON Omega Ratio Rank: 8787
Omega Ratio Rank
ETON Calmar Ratio Rank: 8585
Calmar Ratio Rank
ETON Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBS vs. ETON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SBSETONDifference
Sharpe ratioReturn per unit of total volatility

-1.03

Sortino ratioReturn per unit of downside risk

-1.08

Omega ratioGain probability vs. loss probability

1.21

1.36

-0.16

Calmar ratioReturn relative to maximum drawdown

1.55

3.27

-1.72

Martin ratioReturn relative to average drawdown

4.65

6.73

-2.08

SBS vs. ETON - Sharpe Ratio Comparison

The current SBS Sharpe Ratio is 1.14, which is lower than the ETON Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of SBS and ETON, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SBS vs. ETON - Drawdown Comparison

The maximum SBS drawdown since its inception was -76.49%, roughly equal to the maximum ETON drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for SBS and ETON.


Loading charts...

Drawdown Indicators


SBSETONDifference

Max Drawdown

Largest peak-to-trough decline

-76.49%

-79.94%

+3.45%

Max Drawdown (1Y)

Largest decline over 1 year

-24.88%

-36.17%

+11.29%

Max Drawdown (3Y)

Largest decline over 3 years

-24.88%

-45.65%

+20.77%

Max Drawdown (5Y)

Largest decline over 5 years

-30.35%

-70.42%

+40.07%

Max Drawdown (10Y)

Largest decline over 10 years

-61.91%

Current Drawdown

Current decline from peak

-22.90%

-9.74%

-13.16%

Average Drawdown

Average peak-to-trough decline

-25.70%

-37.58%

+11.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.28%

17.56%

-9.28%

Volatility

SBS vs. ETON - Volatility Comparison

The current volatility for Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is 8.92%, while Eton Pharmaceuticals Inc (ETON) has a volatility of 17.63%. This indicates that SBS experiences smaller price fluctuations and is considered to be less risky than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBSETONDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.92%

17.63%

-8.71%

Volatility (6M)

Calculated over the trailing 6-month period

24.61%

40.49%

-15.88%

Volatility (1Y)

Calculated over the trailing 1-year period

33.86%

54.85%

-20.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.90%

63.41%

-26.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.51%

63.87%

-20.36%

Dividends

SBS vs. ETON - Dividend Comparison

SBS's dividend yield for the trailing twelve months is around 2.33%, while ETON has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ETON
Eton Pharmaceuticals Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SBS
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
2.33%4.68%1.96%1.66%1.88%0.97%2.93%1.99%3.86%2.76%0.65%1.91%

Financials

SBS vs. ETON - Financials Comparison

This section allows you to compare key financial metrics between Companhia de Saneamento Básico do Estado de São Paulo - SABESP and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
9.78B
24.27M
(SBS) Total Revenue
(ETON) Total Revenue
Please note, different currencies. SBS values in BRL, ETON values in USD

SBS vs. ETON - Profitability Comparison

The chart below illustrates the profitability comparison between Companhia de Saneamento Básico do Estado de São Paulo - SABESP and Eton Pharmaceuticals Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
38.8%
60.7%
Portfolio components
SBS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Companhia de Saneamento Básico do Estado de São Paulo - SABESP reported a gross profit of 3.79B and revenue of 9.78B. Therefore, the gross margin over that period was 38.8%.

ETON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a gross profit of 14.74M and revenue of 24.27M. Therefore, the gross margin over that period was 60.7%.

SBS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Companhia de Saneamento Básico do Estado de São Paulo - SABESP reported an operating income of 3.33B and revenue of 9.78B, resulting in an operating margin of 34.1%.

ETON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported an operating income of 2.41M and revenue of 24.27M, resulting in an operating margin of 10.0%.

SBS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Companhia de Saneamento Básico do Estado de São Paulo - SABESP reported a net income of 1.72B and revenue of 9.78B, resulting in a net margin of 17.6%.

ETON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a net income of 1.55M and revenue of 24.27M, resulting in a net margin of 6.4%.


Frequently Asked Questions


SBS and ETON have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ETON has higher volatility (17.63%) compared to SBS (8.92%). In terms of maximum drawdown, SBS dropped -76.49% vs ETON's -79.94%.

ETON currently has the higher Sharpe Ratio (2.16 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBS and ETON

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer